INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | -100.0% | 763 | -98.8% | 0.00% | – |
| Q1 2018 | $35,000 | -28.6% | 61,763 | +0.4% | 0.00% | – |
| Q4 2017 | $49,000 | -86.1% | 61,508 | -82.7% | 0.00% | – |
| Q3 2017 | $352,000 | -68.7% | 355,563 | -34.0% | 0.00% | -100.0% |
| Q2 2017 | $1,126,000 | -8.6% | 538,957 | +9.5% | 0.00% | +100.0% |
| Q1 2017 | $1,232,000 | +40966.7% | 492,357 | +46480.6% | 0.00% | – |
| Q4 2016 | $3,000 | +200.0% | 1,057 | +312.9% | 0.00% | – |
| Q3 2016 | $1,000 | – | 256 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 256 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 256 | -10.2% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 285 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 285 | -0.3% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 286 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 286 | -4.3% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 299 | +4.5% | 0.00% | – |
| Q2 2014 | $1,000 | 0.0% | 286 | 0.0% | 0.00% | – |
| Q1 2014 | $1,000 | 0.0% | 286 | +0.4% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 285 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 285 | +1935.7% | 0.00% | – |
| Q2 2013 | $0 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,936,000 | $1,549,000 | 0.15% |
| SABBY MANAGEMENT, LLC | 1,083,637 | $867,000 | 0.08% |
| FIRST FOUNDATION ADVISORS | 489,172 | $391,000 | 0.02% |
| Argent Trust Co | 59,693 | $48,000 | 0.02% |
| Verity Asset Management, Inc. | 30,000 | $24,000 | 0.02% |
| WealthShield Partners, LLC | 16,500 | $14,000 | 0.01% |
| THOMPSON DAVIS & CO., INC. | 2,500 | $2,000 | 0.01% |
| Belpointe Asset Management LLC | 31,844 | $25,000 | 0.01% |
| Virtu Financial LLC | 27,633 | $22,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $0 | 0.00% |